Herceptin Market Size, Share & Trends Analysis Report By Product (Biosimilar, Biologic) By Application (Breast Cancer, Stomach/Gastric Cancer), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Application
                        1.2.3. Payer
                        1.2.4. Distribution Channel
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Herceptin Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Patent Expiry Analysis
                        3.3.4. Pricing and Reimbursement Scenario
                        3.3.5. M&A and Deals
                        3.3.6. Impact of Generics/Biosimilars
Chapter 4. Herceptin Market: Application Business Analysis
                    4.1. Product Market Share, 2024 & 2030
                    4.2. Product Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
                    4.4. Biologic
                        4.4.1. Biologic Market, 2018 - 2030 (USD Million)
                    4.5. Biosimilar
                        4.5.1. Biosimilar Market, 2018 - 2030 (USD Million)
Chapter 5. Herceptin Market: Application Business Analysis
                    5.1. Application Market Share, 2024 & 2030
                    5.2. Application Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    5.4. Breast Cancer
                        5.4.1. Breast Cancer Market, 2018 - 2030 (USD Million)
                    5.5. Stomach/Gastric Cancer
                        5.5.1. Stomach/Gastric Cancer Market, 2018 - 2030 (USD Million)
Chapter 6. Herceptin Market: Payer Business Analysis
                    6.1. Payer Market Share, 2024 & 2030
                    6.2. Payer Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by Payer, 2018 to 2030 (USD Million)
                    6.4. Commercial/Private
                        6.4.1. Commercial/Private Market, 2018 - 2030 (USD Million)
                    6.5. Public
                        6.5.1. Public Market, 2018 - 2030 (USD Million)
Chapter 7. Herceptin Market: Distribution Channel Business Analysis
                    7.1. Distribution Channel Market Share, 2024 & 2030
                    7.2. Distribution Channel Segment Dashboard
                    7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
                    7.4. Hospital Pharmacy
                        7.4.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
                    7.5. Specialty Pharmacy
                        7.5.1. Specialty Pharmacy Market, 2018 - 2030 (USD Million)
Chapter 8. Herceptin Market: Regional Estimates & Trend Analysis
                    8.1. Regional Market Share Analysis, 2024 & 2030
                    8.2. Regional Market Dashboard
                    8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
                    8.4. North America
                        8.4.1. North America Herceptin Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        8.4.2. U.S.
                            8.4.2.1. Key Country Dynamics
                            8.4.2.2. Target Disease Prevalence
                            8.4.2.3. Regulatory Framework
                            8.4.2.4. Reimbursement Framework
                            8.4.2.5. U.S. Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.4.3. Canada
                            8.4.3.1. Key Country Dynamics
                            8.4.3.2. Target Disease Prevalence
                            8.4.3.3. Regulatory Framework
                            8.4.3.4. Reimbursement Framework
                            8.4.3.5. Canada Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.4.4. Mexico
                            8.4.4.1. Key Country Dynamics
                            8.4.4.2. Target Disease Prevalence
                            8.4.4.3. Regulatory Framework
                            8.4.4.4. Reimbursement Framework
                            8.4.4.5. Mexico Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.5. Europe
                        8.5.1. Europe Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.2. UK
                            8.5.2.1. Key Country Dynamics
                            8.5.2.2. Target Disease Prevalence
                            8.5.2.3. Regulatory Framework
                            8.5.2.4. Reimbursement Framework
                            8.5.2.5. UK Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.3. Germany
                            8.5.3.1. Key Country Dynamics
                            8.5.3.2. Target Disease Prevalence
                            8.5.3.3. Regulatory Framework
                            8.5.3.4. Reimbursement Framework
                            8.5.3.5. Germany Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.4. France
                            8.5.4.1. Key Country Dynamics
                            8.5.4.2. Target Disease Prevalence
                            8.5.4.3. Regulatory Framework
                            8.5.4.4. Reimbursement Framework
                            8.5.4.5. France Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.5. Italy
                            8.5.5.1. Key Country Dynamics
                            8.5.5.2. Target Disease Prevalence
                            8.5.5.3. Regulatory Framework
                            8.5.5.4. Reimbursement Framework
                            8.5.5.5. Italy Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.6. Spain
                            8.5.6.1. Key Country Dynamics
                            8.5.6.2. Target Disease Prevalence
                            8.5.6.3. Regulatory Framework
                            8.5.6.4. Reimbursement Framework
                            8.5.6.5. Spain Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.7. Denmark
                            8.5.7.1. Key Country Dynamics
                            8.5.7.2. Target Disease Prevalence
                            8.5.7.3. Regulatory Framework
                            8.5.7.4. Reimbursement Framework
                            8.5.7.5. Denmark Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.8. Sweden
                            8.5.8.1. Key Country Dynamics
                            8.5.8.2. Target Disease Prevalence
                            8.5.8.3. Regulatory Framework
                            8.5.8.4. Reimbursement Framework
                            8.5.8.5. Sweden Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.9. Norway
                            8.5.9.1. Key Country Dynamics
                            8.5.9.2. Target Disease Prevalence
                            8.5.9.3. Regulatory Framework
                            8.5.9.4. Reimbursement Framework
                            8.5.9.5. Norway Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.6. Asia Pacific
                        8.6.1. Asia Pacific Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.2. Japan
                            8.6.2.1. Key Country Dynamics
                            8.6.2.2. Target Disease Prevalence
                            8.6.2.3. Regulatory Framework
                            8.6.2.4. Reimbursement Framework
                            8.6.2.5. Japan Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.3. China
                            8.6.3.1. Key Country Dynamics
                            8.6.3.2. Target Disease Prevalence
                            8.6.3.3. Regulatory Framework
                            8.6.3.4. Reimbursement Framework
                            8.6.3.5. China Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.4. India
                            8.6.4.1. Key Country Dynamics
                            8.6.4.2. Target Disease Prevalence
                            8.6.4.3. Regulatory Framework
                            8.6.4.4. Reimbursement Framework
                            8.6.4.5. India Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.5. Australia
                            8.6.5.1. Key Country Dynamics
                            8.6.5.2. Target Disease Prevalence
                            8.6.5.3. Regulatory Framework
                            8.6.5.4. Reimbursement Framework
                            8.6.5.5. Australia Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.6. South Korea
                            8.6.6.1. Key Country Dynamics
                            8.6.6.2. Target Disease Prevalence
                            8.6.6.3. Regulatory Framework
                            8.6.6.4. Reimbursement Framework
                            8.6.6.5. South Korea Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.7. Thailand
                            8.6.7.1. Key Country Dynamics
                            8.6.7.2. Target Disease Prevalence
                            8.6.7.3. Regulatory Framework
                            8.6.7.4. Reimbursement Framework
                            8.6.7.5. Thailand Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.7. Latin America
                        8.7.1. Latin America Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.7.2. Brazil
                            8.7.2.1. Key Country Dynamics
                            8.7.2.2. Target Disease Prevalence
                            8.7.2.3. Regulatory Framework
                            8.7.2.4. Reimbursement Framework
                            8.7.2.5. Japan Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.7.3. Argentina
                            8.7.3.1. Key Country Dynamics
                            8.7.3.2. Target Disease Prevalence
                            8.7.3.3. Regulatory Framework
                            8.7.3.4. Reimbursement Framework
                            8.7.3.5. China Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.8. Middle East and Africa
                        8.8.1. Middle East and Africa Herceptin Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                        8.8.2. South Africa
                            8.8.2.1. Key Country Dynamics
                            8.8.2.2. Target Disease Prevalence
                            8.8.2.3. Regulatory Framework
                            8.8.2.4. Reimbursement Framework
                            8.8.2.5. South Africa Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.8.3. Saudi Arabia
                            8.8.3.1. Key Country Dynamics
                            8.8.3.2. Target Disease Prevalence
                            8.8.3.3. Regulatory Framework
                            8.8.3.4. Reimbursement Framework
                            8.8.3.5. Saudi Arabia Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.8.4. UAE
                            8.8.4.1. Key Country Dynamics
                            8.8.4.2. Target Disease Prevalence
                            8.8.4.3. Regulatory Framework
                            8.8.4.4. Reimbursement Framework
                            8.8.4.5. UAE Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.8.5. Kuwait
                            8.8.5.1. Key Country Dynamics
                            8.8.5.2. Target Disease Prevalence
                            8.8.5.3. Regulatory Framework
                            8.8.5.4. Reimbursement Framework
                            8.8.5.5. Kuwait Herceptin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Participant Overview
                    9.2. Company Market Position Analysis
                    9.3. Company Categorization
                    9.4. Strategy Mapping
                    9.5. Company Profiles/Listing
                        9.5.1. Roche Holding AG (Genentech)
                            9.5.1.1. Overview
                            9.5.1.2. Financial Performance
                            9.5.1.3. Product Benchmarking
                            9.5.1.4. Strategic Initiatives
                        9.5.2. Pfizer Inc.
                            9.5.2.1. Overview
                            9.5.2.2. Financial Performance
                            9.5.2.3. Product Benchmarking
                            9.5.2.4. Strategic Initiatives
                        9.5.3. Samsung Bioepis Co., Ltd.
                            9.5.3.1. Overview
                            9.5.3.2. Financial Performance
                            9.5.3.3. Product Benchmarking
                            9.5.3.4. Strategic Initiatives
                        9.5.4. Amgen Inc.
                            9.5.4.1. Overview
                            9.5.4.2. Financial Performance
                            9.5.4.3. Product Benchmarking
                            9.5.4.4. Strategic Initiatives
                        9.5.5. Celltrion Healthcare Co., Ltd.
                            9.5.5.1. Overview
                            9.5.5.2. Financial Performance
                            9.5.5.3. Product Benchmarking
                            9.5.5.4. Strategic Initiatives
                        9.5.6. Biocon Limited
                            9.5.6.1. Overview
                            9.5.6.2. Financial Performance
                            9.5.6.3. Product Benchmarking
                            9.5.6.4. Strategic Initiatives
                        9.5.7. Mylan N.V. (Viatris)
                            9.5.7.1. Overview
                            9.5.7.2. Financial Performance
                            9.5.7.3. Product Benchmarking
                            9.5.7.4. Strategic Initiatives
                        9.5.8. Prestige Biopharma
                            9.5.8.1. Overview
                            9.5.8.2. Financial Performance
                            9.5.8.3. Product Benchmarking
                            9.5.8.4. Strategic Initiatives
                        9.5.9. Shanghai Henlius Biotech, Inc.
                            9.5.9.1. Overview
                            9.5.9.2. Financial Performance
                            9.5.9.3. Product Benchmarking
                            9.5.9.4. Strategic Initiatives
                        9.5.10. AryoGen Pharmed
                            9.5.10.1. Overview
                            9.5.10.2. Financial Performance
                            9.5.10.3. Product Benchmarking
                            9.5.10.4. Strategic Initiatives
                        9.5.11. Dr. Reddy’s Laboratories
                            9.5.11.1. Overview
                            9.5.11.2. Financial Performance
                            9.5.11.3. Product Benchmarking
                            9.5.11.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Herceptin market, by region, 2018 - 2030 (USD Million)
Table 4 Global Herceptin market, by product, 2018 - 2030 (USD Million)
Table 5 Global Herceptin market, by application, 2018 - 2030 (USD Million)
Table 6 Global Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 7 Global Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 8 North America Herceptin market, by country, 2018 - 2030 (USD Million)
Table 9 North America Herceptin market, by product, 2018 - 2030 (USD Million)
Table 10 North America Herceptin market, by application, 2018 - 2030 (USD Million)
Table 11 North America Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 12 North America Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 U.S. Herceptin market, by product, 2018 - 2030 (USD Million)
Table 14 U.S. Herceptin market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 16 U.S. Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 17 Canada Herceptin market, by product, 2018 - 2030 (USD Million)
Table 18 Canada Herceptin market, by application, 2018 - 2030 (USD Million)
Table 19 Canada Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 20 Canada Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 21 Mexico Herceptin market, by product, 2018 - 2030 (USD Million)
Table 22 Mexico Herceptin market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 24 Mexico Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Europe Herceptin market, by country, 2018 - 2030 (USD Million)
Table 26 Europe Herceptin market, by product, 2018 - 2030 (USD Million)
Table 27 Europe Herceptin market, by application, 2018 - 2030 (USD Million)
Table 28 Europe Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 29 Europe Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 30 UK Herceptin market, by product, 2018 - 2030 (USD Million)
Table 31 UK Herceptin market, by application, 2018 - 2030 (USD Million)
Table 32 UK Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 33 UK Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 34 Germany Herceptin market, by product, 2018 - 2030 (USD Million)
Table 35 Germany Herceptin market, by application, 2018 - 2030 (USD Million)
Table 36 Germany Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 37 Germany Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 38 France Herceptin market, by product, 2018 - 2030 (USD Million)
Table 39 France Herceptin market, by application, 2018 - 2030 (USD Million)
Table 40 France Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 41 France Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 42 Italy Herceptin market, by product, 2018 - 2030 (USD Million)
Table 43 Italy Herceptin market, by application, 2018 - 2030 (USD Million)
Table 44 Italy Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 45 Italy Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 46 Spain Herceptin market, by product, 2018 - 2030 (USD Million)
Table 47 Spain Herceptin market, by application, 2018 - 2030 (USD Million)
Table 48 Spain Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 49 Spain Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Norway Herceptin market, by product, 2018 - 2030 (USD Million)
Table 51 Norway Herceptin market, by application, 2018 - 2030 (USD Million)
Table 52 Norway Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 53 Norway Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 54 Denmark Herceptin market, by product, 2018 - 2030 (USD Million)
Table 55 Denmark Herceptin market, by application, 2018 - 2030 (USD Million)
Table 56 Denmark Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 57 Denmark Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 58 Sweden Herceptin market, by product, 2018 - 2030 (USD Million)
Table 59 Sweden Herceptin market, by application, 2018 - 2030 (USD Million)
Table 60 Sweden Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 61 Sweden Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Herceptin market, by country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Herceptin market, by product, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Herceptin market, by application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 67 Japan Herceptin market, by product, 2018 - 2030 (USD Million)
Table 68 Japan Herceptin market, by application, 2018 - 2030 (USD Million)
Table 69 Japan Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 70 Japan Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 71 China Herceptin market, by product, 2018 - 2030 (USD Million)
Table 72 China Herceptin market, by application, 2018 - 2030 (USD Million)
Table 73 China Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 74 China Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 India Herceptin market, by product, 2018 - 2030 (USD Million)
Table 76 India Herceptin market, by application, 2018 - 2030 (USD Million)
Table 77 India Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 78 India Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 79 Australia Herceptin market, by product, 2018 - 2030 (USD Million)
Table 80 Australia Herceptin market, by application, 2018 - 2030 (USD Million)
Table 81 Australia Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 82 Australia Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 83 South Korea Herceptin market, by product, 2018 - 2030 (USD Million)
Table 84 South Korea Herceptin market, by application, 2018 - 2030 (USD Million)
Table 85 South Korea Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 86 South Korea Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 87 Thailand Herceptin market, by product, 2018 - 2030 (USD Million)
Table 88 Thailand Herceptin market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 90 Thailand Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 Latin America Herceptin market, by country, 2018 - 2030 (USD Million)
Table 92 Latin America Herceptin market, by product, 2018 - 2030 (USD Million)
Table 93 Latin America Herceptin market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 95 Latin America Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 Brazil Herceptin market, by product, 2018 - 2030 (USD Million)
Table 97 Brazil Herceptin market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 99 Brazil Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 100 Argentina Herceptin market, by product, 2018 - 2030 (USD Million)
Table 101 Argentina Herceptin market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 103 Argentina Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Herceptin market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Herceptin market, by product, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Herceptin market, by application, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 109 South Africa Herceptin market, by product, 2018 - 2030 (USD Million)
Table 110 South Africa Herceptin market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 112 South Africa Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Herceptin market, by product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Herceptin market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 117 UAE Herceptin market, by product, 2018 - 2030 (USD Million)
Table 118 UAE Herceptin market, by application, 2018 - 2030 (USD Million)
Table 119 UAE Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 120 UAE Herceptin market, by distribution channel, 2018 - 2030 (USD Million)
Table 121 Kuwait Herceptin market, by product, 2018 - 2030 (USD Million)
Table 122 Kuwait Herceptin market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait Herceptin market, by dosage form, 2018 - 2030 (USD Million)
Table 124 Kuwait Herceptin market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Herceptin market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Application outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Herceptin market dynamics
Fig. 12 Herceptin market: Porter’s five forces analysis
Fig. 13 Herceptin market: PESTLE analysis
Fig. 14 Herceptin market by product product (USD Million)
Fig. 15 Biologic product revenue trend in Herceptin market (USD Million)
Fig. 16 Biosimilar product market share analysis (USD Million)
Fig. 17 Herceptin market application segmentation (USD Million)
Fig. 18 Breast cancer treatment revenue share in Herceptin market (USD Million)
Fig. 19 Gastric cancer Herceptin usage trend and forecast (USD Million)
Fig. 20 Herceptin market by payer product (USD Million)
Fig. 21 Commercial/private insurance coverage and adoption trend (USD Million)
Fig. 22 Public insurance reimbursement growth in Herceptin market (USD Million)
Fig. 23 Herceptin distribution channel market share (USD Million)
Fig. 24 Hospital pharmacy distribution analysis for Herceptin (USD Million)
Fig. 25 Specialty pharmacy Herceptin delivery growth trend (USD Million)
Fig. 26 Herceptin market revenue, by region
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 North America Herceptin market, 2018 - 2030 (USD Million)
Fig. 29 U.S. country dynamics
Fig. 30 U.S. Herceptin market, 2018 - 2030 (USD Million)
Fig. 31 Canada country dynamics
Fig. 32 Canada Herceptin market, 2018 - 2030 (USD Million)
Fig. 33 Mexico country dynamics
Fig. 34 Mexico Herceptin market, 2018 - 2030 (USD Million)
Fig. 35 Europe Herceptin market, 2018 - 2030 (USD Million)
Fig. 36 UK country dynamics
Fig. 37 UK Herceptin market, 2018 - 2030 (USD Million)
Fig. 38 Germany country dynamics
Fig. 39 Germany Herceptin market, 2018 - 2030 (USD Million)
Fig. 40 France country dynamics
Fig. 41 France Herceptin market, 2018 - 2030 (USD Million)
Fig. 42 Italy country dynamics
Fig. 43 Italy Herceptin market, 2018 - 2030 (USD Million)
Fig. 44 Spain country dynamics
Fig. 45 Spain Herceptin market, 2018 - 2030 (USD Million)
Fig. 46 Norway country dynamics
Fig. 47 Norway Herceptin market, 2018 - 2030 (USD Million)
Fig. 48 Sweden country dynamics
Fig. 49 Sweden Herceptin market, 2018 - 2030 (USD Million)
Fig. 50 Denmark country dynamics
Fig. 51 Denmark Herceptin market, 2018 - 2030 (USD Million)
Fig. 52 Asia-Pacific Herceptin market, 2018 - 2030 (USD Million)
Fig. 53 Japan country dynamics
Fig. 54 Japan Herceptin market, 2018 - 2030 (USD Million)
Fig. 55 China country dynamics
Fig. 56 China Herceptin market, 2018 - 2030 (USD Million)
Fig. 57 India country dynamics
Fig. 58 India Herceptin market, 2018 - 2030 (USD Million)
Fig. 59 Australia country dynamics
Fig. 60 Australia Herceptin market, 2018 - 2030 (USD Million)
Fig. 61 South Korea country dynamics
Fig. 62 South Korea Herceptin market, 2018 - 2030 (USD Million)
Fig. 63 Thailand country dynamics
Fig. 64 Thailand Herceptin market, 2018 - 2030 (USD Million)
Fig. 65 Latin America Herceptin market, 2018 - 2030 (USD Million)
Fig. 66 Brazil country dynamics
Fig. 67 Brazil Herceptin market, 2018 - 2030 (USD Million)
Fig. 68 Argentina country dynamics
Fig. 69 Argentina Herceptin market, 2018 - 2030 (USD Million)
Fig. 70 Middle East & Africa (MEA) Herceptin market, 2018 - 2030 (USD Million)
Fig. 71 South Africa country dynamics
Fig. 72 South Africa Herceptin market, 2018 - 2030 (USD Million)
Fig. 73 Saudi Arabia country dynamics
Fig. 74 Saudi Arabia Herceptin market, 2018 - 2030 (USD Million)
Fig. 75 UAE country dynamics
Fig. 76 UAE Herceptin market, 2018 - 2030 (USD Million)
Fig. 77 Kuwait country dynamics
Fig. 78 Kuwait Herceptin market, 2018 - 2030 (USD Million)
Fig. 79 Company categorization
Fig. 80 Company market position analysis
Fig. 81 Strategic framework